HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

trans-Fatty acids, insulin resistance/diabetes, and cardiovascular disease risk: should policy decisions be based on observational cohort studies, or should we be waiting for results from randomized placebo-controlled trials?

AuthorsKonstantinos N Aronis, Richard J Joseph, George L Blackburn, Christos Mantzoros
JournalMetabolism: clinical and experimental (Metabolism) Vol. 60 Issue 7 Pg. 901-5 (Jul 2011) ISSN: 1532-8600 [Electronic] United States
PMID21684360 (Publication Type: Comment, Editorial)
Chemical References
  • Dietary Fats, Unsaturated
  • Trans Fatty Acids
Topics
  • Cardiovascular Diseases (diet therapy, etiology)
  • Cohort Studies
  • Diabetes Mellitus, Type 2 (complications, diet therapy, etiology)
  • Dietary Fats, Unsaturated (adverse effects)
  • Female
  • Health Policy
  • Humans
  • Insulin Resistance
  • Male
  • Randomized Controlled Trials as Topic
  • Trans Fatty Acids (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: